title: Treatment of peritoneal carcinomatosis of colorectal origin.
abstract: The management of peritoneal carcinomatosis from colon cancer remains a controversial issue. Peritoneal carcinomatosis is associated with worse survival and has led to an aggressive treatment that combines surgery and intraperitoneal chemotherapy (IPC). This review will describe the rationale behind this treatment and the current controversy surrounding it.
authors.affiliation: From the Memorial Sloan Kettering Cancer Center, New York, NY; Massachusetts General Hospital, Boston, MA.
authors.forename: Andrea
authors.initials: A
authors.lastname: Cercek
authors.affiliation: From the Memorial Sloan Kettering Cancer Center, New York, NY; Massachusetts General Hospital, Boston, MA.
authors.forename: James C
authors.initials: JC
authors.lastname: Cusack
authors.affiliation: From the Memorial Sloan Kettering Cancer Center, New York, NY; Massachusetts General Hospital, Boston, MA.
authors.forename: David P
authors.initials: DP
authors.lastname: Ryan
mesh_terms: D015179:Colorectal Neoplasms / Q000473:pathology* / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D009362:Neoplasm Metastasis; D010534:Peritoneal Neoplasms / Q000473:pathology / Q000556:secondary* / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic